Search results
Pages
-
- GC/MS analysis of cerebrospinal fluid of familial hemiplegic migraine patients and a transgenic FHM mouse model; report from lumina
-
- Acute treatment of migraine with the selective 5-HTIF receptor agonist lasmiditan - A randomised proof-of-concept trial
-
- Progression and consequences of brain lesions in migraine: the population-based camera-2 nine year follow-up MRI study
-
- Acute treatment of migraine with the selective 5-HT1F receptor agonist lasmiditan--a randomised proof-of-concept trial
-
- Severe and Progressive Neurotransmitter Release Aberrations in Familial Hemiplegic Migraine Type 1 Cacna1a S218L Knock-in Mice
-
- Familial hemiplegic migraine Ca(V)2.1 channel mutation R192Q enhances ATP-gated P2X3 receptor activity of mouse sensory ganglion neurons mediating trigeminal pain
-
- Quantitative cortical synapse proteomics of a transgenic migraine mouse model with mutated Ca(v)2.1 calcium channels
-
- Frovatriptan versus zolmitriptan for the acute treatment of migraine: a double-blind, randomized, multicenter, Italian study
-
- Efficacy and safety of a single intrathecal methylprednisolone bolus in chronic complex regional pain syndrome
-
- Migraine is associated with an increased risk of deep white matter lesions, subclinical posterior circulation infarcts and brain iron accumulation: The population-based MRI CAMERA study
-
- High Cortical Spreading Depression Susceptibility and Migraine-Associated Symptoms in Ca(V)2.1 S218L Mice